COMMUNIQUÉS West-GlobeNewswire

Endocyte Announces Presentations on PSMA-617 at the 2018 Society of Nuclear Medicine and Molecular Imaging Annual Meeting
22/06/2018
Presentations highlight Endocyte’s alpha and beta-emitting radioligand therapies WEST LAFAYETTE, Ind., June 22, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted [...]
The American Health Council Appoints Preeti Rana, MD to Physicians Board
22/06/2018
NEW YORK, June 22, 2018 (GLOBE NEWSWIRE) -- The American Health Council recently appointed Preeti Rana, MD to its Board of Physicians for her outstanding dedication to improve others’ lives at her practice, Preeti Rana [...]
Endocrinologist & Researcher Dr. Dara P. Schuster Named CEO of T1D Exchange
22/06/2018
BOSTON, June 22, 2018 (GLOBE NEWSWIRE) -- T1D Exchange , a patient-centered research organization dedicated to accelerating therapies and improving care for people with type 1 diabetes (T1D), today announced that [...]
Mustang Bio Announces Opening of CAR T Cell Therapy Manufacturing Facility in Worcester, Mass.
22/06/2018
UMass Medicine Science Park facility to support clinical development and commercialization of CAR T pipeline NEW YORK, June 22, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ:MBIO), a Fortress Biotech ( [...]
Pernix Therapeutics Announces Result of Bid Process for Acquisition of Worldwide Rights to Contrave® for Weight Loss
22/06/2018
MORRISTOWN, N.J., June 22, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced that Nalpropion Pharmaceuticals, Inc. (“Nalpropion”), the special [...]
Coherus BioSciences Announces New Employment Inducement Grants
22/06/2018
REDWOOD CITY, Calif., June 22, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today announced that effective June 21, 2018, the compensation committee of the company’s board of directors granted 8 new [...]
Avivagen to Exhibit Vivamune at SuperZoo
22/06/2018
OTTAWA, June 22, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV)(“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and [...]
Shire plc : Rule 2.9 Announcement
22/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 22 June 2018 Shire [...]
Shire plc: Large-Scale European Review Suggests Disparity in Symptom Recognition and Standardized Treatment for Metastatic Adenocarcinoma of the Pancreas
22/06/2018
Large-Scale European Review Suggests Disparity in Symptom Recognition and Standardized Treatment for Metastatic Adenocarcinoma of the Pancreas New analyses from the global phase III NAPOLI-1 study, also presented at the [...]
UK's MHRA renews Early Access to Medicines Scheme Scientific Opinion for Santhera's Raxone® (idebenone) in Duchenne Muscular Dystrophy
22/06/2018
Pratteln, Switzerland, June 22, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces that the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has renewed the Early Access to Medicines Scheme (EAMS) [...]
Autolus Announces Pricing of Initial Public Offering
22/06/2018
Autolus Announces Pricing of Initial Public Offering LONDON – 22 June, 2018 – Autolus Therapeutics plc (“Autolus”), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, [...]
electroCore, Inc. Announces Pricing of Initial Public Offering
22/06/2018
BASKING RIDGE, N.J., June 21, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) today announced the pricing of its initial public offering of 5,200,000 shares of common stock at a public offering price of $15. [...]
Medtronic Receives FDA Approval of New Pediatric Indication for the MiniMed(TM) 670G Hybrid Closed Loop System in Children Ages 7-13
22/06/2018
DUBLIN- June 21, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) has approved the use of the MiniMed(TM) 670G system in patients [...]
Kane Biotech to Showcase bluestem™ Pet Oral Care Products and New Skin Care Shampoo at SuperZoo
21/06/2018
WINNIPEG, Manitoba, June 21, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to announce that it will be attending SuperZoo, North America’s leading [...]
IGC Announces Financial Results for Fiscal Year Ended March 31, 2018
21/06/2018
BETHESDA, Md., June 21, 2018 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC) announces financial results for the fiscal year ended March 31, 2018. “In fiscal 2018, the Company’s focus was to [...]
iKang Announces Unaudited Financial Results for the Fiscal Fourth Quarter and the Fiscal Year 2017 Ended March 31, 2018
21/06/2018
BEIJING, June 21, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq:KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced [...]
Loop Industries, Inc. activates breakthrough Generation II technology
21/06/2018
Technology enhancement reinforces Loop’s position as innovation leader in the PET and polyester fiber upcycling industry TERREBONNE, Quebec, June 21, 2018 (GLOBE NEWSWIRE) -- Today, Loop Industries, Inc. (Nasdaq:LOOP) [...]
Cooper Wellness Strategies Integrates Meritage Healthcare Strategies Services
21/06/2018
Cooper Appoints David Evans as CWS Vice President DALLAS, June 21, 2018 (GLOBE NEWSWIRE) -- Cooper Aerobics announces the integration of Meritage Healthcare Strategies services with Cooper Wellness Strategies (CWS) to [...]
Optinose Announces Publication of Pivotal Efficacy and Long-Term Safety Data for XHANCE in Peer Reviewed Journals
21/06/2018
NAVIGATE II: XHANCE produced significant improvement in both co-primary outcome measures, congestion/obstruction at week four and total polyp grade at week 16 EXHANCE-12: Over one year of treatment, XHANCE 372 mcg twice [...]

Pages